You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: April 27, 2025

Drug Price Trends for NDC 54436-0012


✉ Email this page to a colleague

« Back to Dashboard


Best Wholesale Price for NDC 54436-0012

These are wholesale prices available to the US Federal Government which, by law, must be the best prices available under comparable terms and conditions
Drug Name Vendor NDC Count Price ($) Price/Unit ($) Dates Price Type
OTREXUP 12.5MG/0.4ML INJ Assertio Therapeutics, Inc. 54436-0012-04 4X0.4ML 321.63 2022-04-19 - 2025-06-30 FSS
OTREXUP 12.5MG/0.4ML INJ Assertio Therapeutics, Inc. 54436-0012-04 4X0.4ML 348.00 2023-01-01 - 2025-06-30 FSS
OTREXUP 12.5MG/0.4ML INJ Assertio Therapeutics, Inc. 54436-0012-04 4X0.4ML 523.43 2024-01-01 - 2025-06-30 FSS
>Drug Name >Vendor >NDC >Count >Price ($) >Price/Unit ($) >Dates >Price Type
Price type key: Federal Supply Schedule (FSS): generally available to all Federal Govt agencies / 'BIG4' prices: VA, DoD, Public Health & Coast Guard only / National Contracts (NC): Available to specific agencies

Market Analysis and Price Projections for NDC 54436-0012

Introduction to NDC 54436-0012

The National Drug Code (NDC) 54436-0012 corresponds to a specific pharmaceutical product, which needs to be identified to conduct a thorough market analysis and price projection. However, the provided sources do not specify the exact drug associated with this NDC. For the purpose of this analysis, let's assume it is a prescription drug, given the context of NDC codes.

Understanding NDC Codes and Drug Listings

NDC codes, like 54436-0012, are unique identifiers assigned by the FDA to each drug product. The FDA's National Drug Code Directory contains detailed information about these drugs, including their active ingredients, dosage forms, and marketing status[1].

Market Trends in the Pharmaceutical Industry

The pharmaceutical industry is undergoing significant changes driven by technological advancements, regulatory shifts, and market dynamics.

Role of AI and Gene Editing

AI is revolutionizing drug development by accelerating the identification of potential compounds and predicting the effectiveness and safety of drugs. This has reduced the time and cost associated with bringing new drugs to market, a trend expected to continue in 2025[3].

Specialty Pharmaceuticals

Specialty pharmaceuticals, which treat complex or chronic conditions, are a significant driver of drug price inflation. Vizient projects a 3.8% increase in drug prices, largely driven by specialty pharmaceuticals, including weight loss drugs and gene therapies[4].

Drug Price Transparency

Efforts to increase drug price transparency, such as Oregon's Drug Price Transparency Program, highlight the variability in price increases and the need for better oversight across the pharmaceutical supply chain. This includes monitoring interactions between manufacturers, health insurers, pharmacy benefit managers (PBMs), and other entities[2].

Price Projections

General Trends

  • The overall drug price inflation is projected to be around 3.8%, with specialty pharmaceuticals being a major contributor[4].
  • Biosimilars, which are expected to grow in market share, may offer some price relief, but their impact on overall prices is likely to be minimal in the short term[4].

Specific to NDC 54436-0012

Without specific details on the drug associated with NDC 54436-0012, it is challenging to provide precise price projections. However, here are some general considerations:

  • If it is a specialty drug: It may follow the trend of a 4.18% price increase, as projected for specialty medications[4].
  • If it is a generic or biosimilar: The price increase might be lower, potentially around 0.55% as seen with biosimilars[4].
  • Regulatory and Transparency Factors: Any drug subject to transparency programs and regulatory oversight might see more stable or even reduced price increases due to increased accountability[2].

Factors Influencing Drug Prices

Pharmaceutical Supply Chain

The price of a prescription drug is influenced by various factors, including interactions and financial negotiations between pharmaceutical supply chain entities such as manufacturers, PBMs, health insurers, and pharmacies. Transparency across this supply chain is crucial for understanding and managing price increases[2].

Technological Advancements

Technologies like AI, gene editing, and blockchain are making drug development faster and more efficient. However, these advancements also introduce new costs and complexities that could impact pricing[3].

Regulatory Environment

Regulatory changes, such as the creation of drug affordability boards and the implementation of upper payment limits, could significantly impact drug prices. These measures aim to control costs but may also affect the profitability and innovation within the pharmaceutical industry[2].

Key Takeaways

  • Market Dynamics: The pharmaceutical market is driven by technological advancements, regulatory changes, and the increasing importance of specialty pharmaceuticals.
  • Price Projections: General trends suggest a 3.8% increase in drug prices, with specialty drugs leading the way.
  • Specific Drug Analysis: Without specific details on the drug associated with NDC 54436-0012, precise price projections are challenging, but it is likely to follow broader industry trends.
  • Regulatory and Transparency: Efforts to increase transparency and regulatory oversight are critical for managing and predicting drug price changes.

FAQs

  1. What is the National Drug Code (NDC) and how is it used?

    • The NDC is a unique three-segment number assigned by the FDA to identify drug products. It is used in the FDA’s National Drug Code Directory to list and track all drugs manufactured, prepared, propagated, compounded, or processed for sale in the U.S.[1].
  2. How are drug prices influenced by the pharmaceutical supply chain?

    • Drug prices are influenced by interactions and financial negotiations between various entities in the supply chain, including manufacturers, PBMs, health insurers, and pharmacies[2].
  3. What role does AI play in drug development?

    • AI accelerates the identification of potential compounds, predicts drug effectiveness and safety, and reduces the time and cost associated with bringing new drugs to market[3].
  4. What are the projections for drug price inflation in 2024?

    • Vizient projects a 3.8% increase in drug prices, driven largely by specialty pharmaceuticals[4].
  5. How do biosimilars impact drug prices?

    • Biosimilars are expected to grow in market share and may offer some price relief, with a projected price increase of only 0.55% compared to their originator products[4].

Sources

  1. FDA's National Drug Code Directory - FDA
  2. Prescription Drug Price Transparency Results and Recommendations - Oregon Drug Price Transparency Program
  3. The Future of Pharma: 2025's Key Trends To Know - Laboratorios Rubio
  4. Vizient Projects 3.8% Drug Price Increase Driven by Specialty Pharmaceuticals - Vizient Inc.

More… ↓

⤷  Try for Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.